Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06657924Phase 2Recruiting
Phase 2, randomised trial of tranexamic acid in hemorrhage (2 arms). Primary endpoint: Perioperative change in hemoglobin at 60 days. Started Feb 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06657924.